Zobrazeno 1 - 9
of 9
pro vyhledávání: '"I. Bultink"'
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/0f4cafcf806b44f6a8af311836d84e2a
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/ee9e0ae745d44b50a806cf7197865e8f
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7a9fb16ee5a63c09857427228dd6514
https://doi.org/10.1136/lupus-2022-elm2022.186
https://doi.org/10.1136/lupus-2022-elm2022.186
Autor:
J. De Jongh, R. Hemke, G. C. J. Zwezerijnen, M. Yaqub, I. Van der Horst-Bruinsma, M. G. H. Van de Sande, A. Van Kuijk, I. Bultink, L. Burgemeister, N. M. A. Van Dillen, A. Voskuyl, C. J. Van der Laken
Publikováno v:
Annals of the Rheumatic Diseases. 81:859-860
BackgroundPsoriatic arthritis (PsA) can present with peripheral (i.e. arthritis, enthesitis, dactylitis) and/or axial (spondyloarthritis) manifestations. Positron Emission Tomography (PET) may be a promising imaging technique for detection of whole b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::842ee9c92ad6627adabac79dad1e7f81
https://doi.org/10.1136/annrheumdis-2022-eular.1259
https://doi.org/10.1136/annrheumdis-2022-eular.1259
Publikováno v:
Annals of the Rheumatic Diseases. 81:92-93
BackgroundIntercurrent infections are presumed potential triggers of systemic lupus erythematosus (SLE) disease flares.(1) However, most of the evidence is obtained from a limited number of observational studies, and the results of these studies are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49767ca8cfba16a31cc1fa9d3e302bf8
https://doi.org/10.1136/annrheumdis-2022-eular.848
https://doi.org/10.1136/annrheumdis-2022-eular.848
Publikováno v:
Annals of the Rheumatic Diseases. 81:90.2-91
BackgroundTreat-to-target (T2T) is a generally accepted treatment concept in rheumatology care. It is assumed that T2T could significantly improve systemic lupus erythematosus (SLE) care and the patients’ outcomes. However, T2T has not yet been stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1e9c12c87de156bf8e60823c77f2867
https://doi.org/10.1136/annrheumdis-2022-eular.3458
https://doi.org/10.1136/annrheumdis-2022-eular.3458
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Mosca M; Department of Clinical and Experimental Medicine, University of Pisa, Italy. marta.mosca@unipi.it., Andersen J; Lupus Europe Patient Advisory Network, Lupus Europe, Brussels, Belgium., Wildman P; Advocacy & Government Relations, Lupus Foundation of America and World Lupus Federation, Washington DC, USA., Manzi S; Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, USA., Amoura Z; French National Reference Centre for Systemic Lupus Erythematosus, Pitié-Salpêtrière Hospital, Paris, France., Bultink I; Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Monticielo OA; Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Navarra S; Department of Rheumatology, University of Santo Tomas Hospital, Manila, Philippines., Pettersson S; Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.